---
title: "CHANG CARMEN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/699c8ff6-3e09-52f0-8d35-06e358d5fa59
json: https://whiteintel.dev/api/public/dossier/699c8ff6-3e09-52f0-8d35-06e358d5fa59
identifier: sec:0001746342
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CHANG CARMEN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001746342`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/699c8ff6-3e09-52f0-8d35-06e358d5fa59  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/699c8ff6-3e09-52f0-8d35-06e358d5fa59  

## Ownership & control

### Holdings / subsidiaries

- **Coursera, Inc.** (director) — https://whiteintel.dev/entity/1abdb9f5-590f-582a-885f-0e9d71f83a02
- **Trevi Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/2aa1d803-20fb-5be5-ab60-771eefc879d2
- **SPYGLASS OPHTHALMICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/5e1fe159-faae-56de-abf1-40df3ed5be5c
- **Korro Bio, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/71e9bcfd-4176-551b-b776-01b734a2fd82
- **NeueHealth, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a6159516-b1f2-5c09-909e-d32c8bccdff7
- **NeueHealth, Inc.** (director) — https://whiteintel.dev/entity/a6159516-b1f2-5c09-909e-d32c8bccdff7
- **Marker Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/1cdd4569-686b-5a8f-a51c-7a80d34ee9f8
- **MBX Biosciences, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/6af50270-7dd4-5262-8756-e6fc9afb96e3
- **Savara Inc** (tenpercentowner) — https://whiteintel.dev/entity/0e32f3cb-61c4-5fb8-be01-0d6cd6f7999e
- **Mirum Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a485ead8-2cff-5533-b09d-c62eabdf701d
- **AKOUOS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/bb6adb1d-08b1-50ac-b661-f137cc05e729
- **GENOCEA BIOSCIENCES INC** (tenpercentowner) — https://whiteintel.dev/entity/58861c98-cb12-5bb9-b347-0a7d1eb6ca32

…and **6** more subsidiaries/holdings. Resolve the full list with `get_dossier` on the WhiteIntel MCP (`npx -y @whiteintel/mcp-server`) or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **CHANG CARMEN** — https://whiteintel.dev/entity/699c8ff6-3e09-52f0-8d35-06e358d5fa59 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CHANG CARMEN**. Human view: https://whiteintel.dev/entity/699c8ff6-3e09-52f0-8d35-06e358d5fa59 · Structured JSON: https://whiteintel.dev/api/public/dossier/699c8ff6-3e09-52f0-8d35-06e358d5fa59._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._